Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's Disease

Moertel, 1957, Blood, 12, 788, 10.1182/blood.V12.9.788.788

10.1097/00000441-195909000-00009

Berg, 1967, J Natl Cancer Inst, 38, 741

Whitelaw, 1968, Can Med Assoc J, 99, 291

10.1016/S0140-6736(75)92007-3

Toland, 1975, Blood, 46, 1013

10.1002/1097-0142(197710)40:4+<1917::AID-CNCR2820400824>3.0.CO;2-W

10.1002/1097-0142(197710)40:4+<1912::AID-CNCR2820400823>3.0.CO;2-D

10.1002/1097-0142(197709)40:3<1280::AID-CNCR2820400343>3.0.CO;2-A

10.1056/NEJM197712082972303

10.1056/NEJM197707282970402

10.1002/1097-0142(197403)33:3<657::AID-CNCR2820330311>3.0.CO;2-D

10.1002/1097-0142(197709)40:3<959::AID-CNCR2820400302>3.0.CO;2-3

Cardinali, 1975, Haematologica (Pavia), 60, 236

10.1159/000224905

Carbone, 1971, Cancer Res, 31, 1860

Lukes, 1971, Cancer Res, 31, 1755

Rappaport H: Tumors of the Hematopoietic System (Atlas of Tumor Pathology, Section 3, Fasc 8). Washington, DC, Armed Forces Institute of Pathology, 1966

10.1056/NEJM197803022980903

Kaplan, 1973, Natl Cancer Inst Monogr, 36, 363

10.7326/0003-4819-77-1-1

Rosenberg SA, Kaplan HS, Glatstein E, et al: The role of adjuvant MOPP in the radiation management of Hodgkin's disease: a progress report after eight years on the Stanford trials, Adjuvant Therapy of Cancer. Edited by SE Salmon, SE Jones. Amsterdam, Elsevier/North Holland, 1977, pp 505–515

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

Kaplan HS: Hodgkin's Disease. Cambridge, Massachusetts, Harvard University Press, 1972, pp 279–308

10.7326/0003-4819-73-6-881

10.2307/2281868

Coltman, 1975, Cancer Chemother Rep, 6, 375

10.7326/0003-4819-85-4-417

10.1002/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C

10.1016/0002-9343(75)90600-2

10.1136/pgmj.53.615.52

10.1159/000208003

10.1016/S0140-6736(75)92356-9

Berard, 1969, Bull WHO, 40, 601

10.1056/NEJM197609232951301

10.1016/0002-9343(76)90151-0

10.1016/0002-9343(70)90057-4

10.1056/NEJM197711172972001

Purtilo, 1977, Semin Oncol, 4, 335